• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Novel paediatric anticoagulants: a review of the current literature.

作者信息

Chan Veronica H T, Monagle Paul, Massicotte Patti, Chan Anthony K C

机构信息

Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.

出版信息

Blood Coagul Fibrinolysis. 2010 Mar;21(2):144-51. doi: 10.1097/mbc.0b013e328335f1d2.

DOI:10.1097/mbc.0b013e328335f1d2
PMID:20135753
Abstract

There are many limitations with respect to anticoagulants currently used in standard paediatric practice for prophylaxis and treatment of thrombosis: heparin, low molecular-weight heparin, and warfarin. Factors such as pharmacokinetic and dosing variability are further exacerbated by properties of the immature haemostatic system of children. These shortcomings necessitate exploring alternative anticoagulants in the paediatric population. In this review, we discuss several promising direct thrombin inhibitors and factor Xa inhibitors, and synthesize relevant drug information and clinical experience from the limited available case reports, case series, and nonrandomized dose-finding trials published to date.

摘要

相似文献

1
Novel paediatric anticoagulants: a review of the current literature.
Blood Coagul Fibrinolysis. 2010 Mar;21(2):144-51. doi: 10.1097/mbc.0b013e328335f1d2.
2
Emerging anticoagulants.新兴抗凝剂。
Curr Med Chem. 2012;19(20):3388-416. doi: 10.2174/092986712801215847.
3
New anticoagulants: anti IIa vs anti Xa--is one better?新型抗凝剂：抗凝血酶IIa与抗凝血酶Xa——哪种更好？
J Thromb Thrombolysis. 2006 Feb;21(1):67-72. doi: 10.1007/s11239-006-5579-4.
4
New anticoagulants.新型抗凝剂
Hematology Am Soc Hematol Educ Program. 2006:450-6. doi: 10.1182/asheducation-2006.1.450.
5
The new anticoagulants.新型抗凝剂
Perspect Vasc Surg Endovasc Ther. 2007 Sep;19(3):332-5. doi: 10.1177/1531003507304441.
6
Role of current and emerging antithrombotics in thrombosis and cancer.当前及新型抗栓药物在血栓形成与癌症中的作用
Drugs Today (Barc). 2006 May;42(5):331-50. doi: 10.1358/dot.2006.42.5.973580.
7
The promise of novel direct oral anticoagulants.新型直接口服抗凝药物的前景。
Best Pract Res Clin Haematol. 2012 Sep;25(3):351-60. doi: 10.1016/j.beha.2012.06.004. Epub 2012 Jul 31.
8
Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.治疗静脉血栓栓塞症患者：初始策略与长期二级预防
Semin Vasc Med. 2005 Aug;5(3):276-84. doi: 10.1055/s-2005-916167.
9
New anticoagulants in children.
Hematology Am Soc Hematol Educ Program. 2008:245-50. doi: 10.1182/asheducation-2008.1.245.
10
A preliminary assessment of the critical differences between novel oral anticoagulants currently in development.对目前正在研发的新型口服抗凝剂之间关键差异的初步评估。
J Clin Pharmacol. 2005 Sep;45(9):1004-17. doi: 10.1177/0091270005278084.

引用本文的文献

1
Alternative anticoagulation during cardiovascular procedures in pediatric patients with heparin-induced thrombocytopenia.肝素诱导的血小板减少症患儿心血管手术期间的替代抗凝治疗。
J Extra Corpor Technol. 2012 Jun;44(2):69-74.
2
Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.新生儿和儿童的抗血栓治疗：抗血栓治疗和血栓预防，第 9 版：美国胸科医师学会基于证据的临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e737S-e801S. doi: 10.1378/chest.11-2308.